Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine Gerhard EisenbrandFrankie HippeStephan Muehlbeyer Review 31 August 2004 Pages: 627 - 635
Alterations in gene expression associated with the overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, during human hepatocarcinogenesis Yae KanaiYoshimasa SaitoSetsuo Hirohashi Original Paper 28 July 2004 Pages: 636 - 644
Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal? Maurie Markman Original Paper 05 August 2004 Pages: 645 - 648
The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy Zairong GaoHans J. BiersackRui An Original Paper 05 August 2004 Pages: 649 - 656
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study P. SchmidJ. KrockerD. Elling Original Paper 20 August 2004 Pages: 657 - 663
The impact of comorbidity on the survival of postmenopausal women with breast cancer G. NagelU. WeddingD. Katenkamp Original Paper 06 August 2004 Pages: 664 - 670
Antisense Tcf inhibits the neoplastic growth of liver cancer cells Ying JiangXin-Da ZhouXin Wu Original Paper 17 June 2004 Pages: 671 - 678
Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer Francisco J. VizosoJosé C. FernándezManuel García-Morán Original Paper 06 August 2004 Pages: 679 - 686
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer L. M. BersteinJ. O. KvatchevskayaJ. H. H. Thijssen Original Paper 18 August 2004 Pages: 687 - 693
